businesspress24.com - MiMedx Group, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against MiMed
 

MiMedx Group, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against MiMedx Group, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 8, 2013 -- MDXG

ID: 1272736

(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 10/15/13 -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased MiMedx Group, Inc. ("MiMedx" or the "Company") (NASDAQ: MDXG) common stock between October 26, 2011 and September 4, 2013.

For more information, click here: .

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (a) the Company violated the Public Health Service Act by unlawfully manufacturing and marketing certain unapproved biologics products; and (b) as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times.

On September 4, 2013, MiMedx acknowledged the receipt of a letter from the Food and Drug Administration ("FDA") which stated that MiMedx's Surgical Biologics unit violated the Public Health Service Act by unlawfully manufacturing and marketing drugs at one of its plants. On this news, MiMedx securities fell more than 36%, to close at $3.85 per share on September 4, 2013.

If you suffered a loss in MiMedx you have until November 8, 2013 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit .

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.



CONTACT:
Levi & Korsinsky, LLP




Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  OvaScience, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against OvaScience, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 15, 2013 -- OVAS
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Nuverra Environmental Solutions, Inc. and Its Board of Directors and a Deadline of November 4, 2013 to Seek a Lead Plaintiff Position -- NES
Bereitgestellt von Benutzer: Marketwired
Datum: 15.10.2013 - 10:52 Uhr
Sprache: Deutsch
News-ID 1272736
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

NEW YORK, NY


Phone:

Kategorie:

Legal


Anmerkungen:


Diese Pressemitteilung wurde bisher 166 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"MiMedx Group, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against MiMedx Group, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 8, 2013 -- MDXG
"
steht unter der journalistisch-redaktionellen Verantwortung von

Levi & Korsinsky, LLP (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Levi & Korsinsky, LLP



 

Who is online

All members: 10 572
Register today: 2
Register yesterday: 0
Members online: 0
Guests online: 123


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.